Bio-Rad Intends to Propose Three New Independent Directors

HERCULES, Calif. — March 13, 2017 — Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a global provider of life science research and clinical diagnostic products, today announced that management intends to propose Jeffrey Edwards, Gregory Hinckley and Arnold Pinkston for election to its Board of Directors at the Company’s 2017 Annual Meeting of Stockholders. Norman... Read more

RedShift BioAnalytics, Inc. Completes $11.0 million Series C Financing

Financing to Drive Commercialization of Next Generation Biotechnology Instrumentation for Drug Discovery and Development BURLINGTON, MA – March 13, 2017 – RedShift BioAnalytics, Inc., an innovative provider of bioanalytical instrumentation for the research, development and manufacturing of protein therapeutic drugs, today announced the closing of the Company’s $11.0 million Series C Preferred Stock financing. The... Read more

VWR Signs European Distribution Agreement for J.T.Baker® and Macron Fine Chemicals™ Laboratory Pharmaceutical and Production Chemistries

Radnor, PA – March 9, 2017 – VWR (NASDAQ: VWR), the leading global independent provider of products and service solutions to laboratory and production customers, is excited to announce an agreement with Avantor® Performance Materials, LLC. This agreement will allow VWR to distribute Avantor’s beaker-to-bulk portfolio of J.T.Baker® and Macron Fine Chemicals™ brand laboratory and... Read more

BASi Names Philip A. Downing Senior Vice President of Preclinical Services

FOR MORE INFORMATION: Company Contact: Jill Blumhoff Chief Financial Officer & Vice President of Finance Phone: 765.497.8381 jblumhoff@BASinc.com WEST LAFAYETTE, IN, March 8, 2017 — Bioanalytical Systems, Inc. (NASDAQ:BASI) (“BASi” or the “Company”) today announced that Philip A. Downing has been promoted to Senior Vice President, Preclinical Services. “ “Philip has demonstrated the ability to... Read more

Bio-Techne Signs Exclusive License Agreement with Multiclonal Therapeutics for Adult “Ground-state” Stem Cell Technology

MINNEAPOLIS, Minnesota (March 7, 2017)- Bio-Techne has entered into an exclusive license agreement with Multiclonal Therapeutics (MCT) to commercialize reagents and media systems in the research reagent field intended for cloning, propagating, and differentiating adult “ground-state” stem cells from healthy and diseased epithelial tissues. Working together, Bio-Techne and MCT will transition this breakthrough technology into... Read more

908 Devices’ Commercialization of Oak Ridge National Laboratory Technology Honored with Federal Laboratory Consortium Award

03.06.17 Life Sciences, Applied Markets, Safety & Security 908 Devices, a pioneer of analytical devices for chemical and biomolecule analysis, today announced that its efforts to develop, build and launch commercial products based on technology licensed from Oak Ridge National Laboratory (ORNL) have been honored by the Federal Laboratory Consortium for Technology Transfer as an... Read more

Smiths Detection Announces New Distribution Partner in Brazil

6 Mar 2017 Edgewood, MD – Smiths Detection Inc., (SDI) a threat detection technology leader, announced today that it has entered into an agreement with Aerotech do Brasil Soluções em Tecnologia Ltda, a subsidiary of Grupo Aerotech,to appoint them as their exclusive distributor to market, sell and maintain their products and services in Brazil. Grupo Aerotech is... Read more

DURAN GROUP Announces New Corporate Identity at Pittcon Creating Leading Global Provider of Laboratory Glassware for the Life Sciences Industry

DURAN GROUP, WHEATON®, and Kimble Unite to Form New Brand DURAN WHEATON KIMBLE, Bringing Together Three Highly Valued International Brands and Excellence in Manufacturing to Put Precision in Your Hands March 06, 2017 07:00 AM Eastern Standard Time MILLVILLE, N.J.–(BUSINESS WIRE)–DURAN GROUP is pleased to announce that following our acquisition of WHEATON Industries and subsequent... Read more